Stock Analysts’ updated eps estimates for Friday, September 1st:
Aaron’s, (NYSE:AAN) had its buy rating reaffirmed by analysts at Stifel Nicolaus. The firm currently has a $55.00 price target on the stock.
AvalonBay Communities (NYSE:AVB) had its buy rating reaffirmed by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $209.00 target price on the stock.
EQT GP Holdings, (NYSE:EQGP) had its hold rating reissued by analysts at Stifel Nicolaus. The firm currently has a $28.00 price target on the stock.
GRAFTON GROUP UT(1 (NASDAQ:GROUF) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Grafton Group plc manufactures and retails building supplies. The Company operates the Plumbase, Buildbase, Jackson, MacNaughton Blair, Chadwicks and Woodies retail chains as well as produces dry mortar. It operates primarily in Britain, Ireland, the Netherlands and Belgium. Grafton Group plc is headquartered in Dublin, Ireland. “
Hammerson (NASDAQ:HMSNF) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Hammerson plc is a real estate investment trust. The company’s portfolio includes commercial buildings, offices and shopping centers. It operates primarily in United Kingdom, Germany and France. Hammerson plc is based in London, the United Kingdom. “
Histogenics Corporation (NASDAQ:HSGX) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Histogenics Corporation is a regenerative medicine company. It is focused on developing and commercializing products in the musculoskeletal segment. The company is developing NeoCart(R) product to provide treatment in the orthopedic space. Histogenics Corporation is headquartered in Waltham, Massachusetts. “
Icon Plc (NASDAQ:ICLR) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $126.00 target price on the stock. According to Zacks, “ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. “
Keysight Technologies (NYSE:KEYS) had its hold rating reissued by analysts at Stifel Nicolaus. The firm currently has a $40.00 price target on the stock.
MGM Resorts International (NYSE:MGM) had its buy rating reiterated by analysts at Stifel Nicolaus.
Enduro Royalty Trust (NYSE:NDRO) had its buy rating reiterated by analysts at Stifel Nicolaus.
Navios Maritime Partners (NYSE:NMM) had its hold rating reissued by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $2.25 target price on the stock.
Owens Corning (NYSE:OC) had its buy rating reaffirmed by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $83.00 price target on the stock.
United Dominion Realty Trust (NYSE:UDR) had its hold rating reissued by analysts at Stifel Nicolaus. They currently have a $41.00 target price on the stock.
Zoetis (NYSE:ZTS) had its buy rating reissued by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $65.00 target price on the stock.
